Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%)

Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000.

This study was designed to assess the effects of blood-free reperfusion with oxygenated or unoxygenated intracoronary perfluorochemical (Fluosol-DA 20%) on myocardial perfusion and to determine its mechanism or mechanisms of limiting no reflow. Twenty-four dogs underwent 90 min of coronary occlusion followed by 210 min of reperfusion and were randomized to either: 1) blood-free reperfusion with intracoronary oxygenated perfluorochemical (20 ml/kg per min) for 20 min followed by blood reperfusion (n = 8); 2) intracoronary unoxygenated perfluorochemical administered as in those treated with oxygenated perfluorochemical (n = 8); and 3) blood reperfusion alone (control) (n = 8). Regional myocardial blood flow was serially determined and global myocardial perfusion was assessed by an intravenous injection of the fluorescent dye (thioflavin-S). Quantitative studies were performed to determine neutrophil infiltration and extent of endothelial injury. Hemodynamic variables were similar in all groups. The zone of impaired perfusion (thioflavin negative), expressed as a percent of the left ventricle, averaged 10 +/- 2%, 6 +/- 2% and 3 +/- 1%, in control and unoxygenated and oxygenated perfluorochemical groups, respectively (control versus oxygenated perfluorochemical p less than 0.004). The reduction in thioflavin-negative area with oxygenated perfluorochemical was associated with a notable recovery of endocardial blood flow (0.97 +/- 0.22 vs. control 0.39 +/- 0.08 ml/min per g; p less than 0.04) at 210 min of reperfusion. The number of capillaries plugged by neutrophils (per 200 capillaries) in thioflavin-negative areas was similar with both oxygenated (5.9 +/- 1.4) and unoxygenated perfluorochemical (5.4 +/- 0.8) treatment and was significantly less than that with the control group (18.9 +/- 3.2, p less than 0.003).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. L. Johnson, L. Schofield, M. Bouchard, L. Chaves, A. Poppas, S. Reinert, P. Zalesky, J. Creech, and D. O. Williams Hyperbaric oxygen solution infused into the anterior interventricular vein at reperfusion reduces infarct size in swine Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2234 - H2240. [Abstract] [Full Text] [PDF]

				P. R. Hansen Role of Neutrophils in Myocardial Ischemia and Reperfusion Circulation, March 15, 1995; 91(6): 1872 - 1885. [Abstract] [Full Text]

				A. Marchbank Fluorocarbon emulsions Perfusion, March 1, 1995; 10(2): 67 - 88. [PDF]

				S. M. Martin, H. Laks, D. C. Drinkwater, D. G. Stein, E. R. Capouya, J. M. Pearl, S. W. Barthel, P. Chang, E. Kaczer, and S. Bhuta Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia Ann. Thorac. Surg., April 1, 1993; 55(4): 954 - 960. [Abstract] [PDF]

				R. E. Maughan, C. Mohan, I. M. Nathan, E. Ascer, P. Damiani, I. J. Jacobowitz, J. N. Cunningham Jr, and C. P. Marini Intrathecal perfusion of an oxygenated perfluorocarbon prevents paraplegia after aortic occlusion Ann. Thorac. Surg., November 1, 1992; 54(5): 818 - 825. [Abstract] [PDF]

				T. Reffelmann, S. L. Hale, G. Li, and R. A. Kloner Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H766 - H772. [Abstract] [Full Text] [PDF]